Home / Grants / Grant

Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)

Updated

Cooperative agreement from the National Institutes of Health, open to small businesses. Closes Nov 5, 2029, 1112 days left.

Be among the first to see new federal grants for small businesses
Only new grants that match, once a day. $29 a month or $290 a year, cancel any time.
Opportunity numberPAR-28-056
AgencyNational Institutes of Health
Funding typeCooperative agreement
FieldHealth
Award ceiling$600,000
Cost sharing or matchingNot required
Assistance listing93.393
PostedSep 25, 2026
ClosesNov 5, 2029 (1112 days left)
Add the deadline toGoogle Calendar

Who can apply

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Description

Through this Notice of Funding Opportunity (NOFO), NCI solicits applications for the Research Units (RUs), one of the two scientific components of the Pancreatic Cancer Detection Consortium (PCDC), to conduct research on early detection of pancreatic ductal adenocarcinoma (PDAC) and characterization of its precursor lesions to identify patients who are at high risk of progression to cancer.

The PCDC will continue to address one of the four research priorities identified in the NCI's 2014 Scientific Framework for Pancreatic Ductal Adenocarcinoma (PDAC). The PCDC will support research for the development and testing of new molecular and imaging biomarkers for detecting PDAC early and for identifying patients at high risk of PDAC (because of genetic factors, family history and/or the presence of precursor lesions) who could be candidates for early intervention.

The PCDC-RUs will consist of multi-disciplinary teams and will undertake studies to: identify and test biomarkers measurable in bodily fluids for early detection of PDAC and/or its precursor lesions; develop molecular- and/or imaging-based markers of pancreatic cysts and determine which lesions are likely to progress to cancer; develop molecular- and/or imaging-based approaches for screening populations at high risk of PDAC; use machine learning and computational approaches towards biomarker discovery and/or validation; and conduct biomarker validation studies.

The PCDC-RUs will also collect longitudinal biospecimens for building a biorepository. Each PCDC-RU is expected to participate in collaborative activities with other PCDC-RUs and share ideas, biospecimens, and data within the Consortium.

Full announcement and how to apply on Grants.gov

Health grants right now

There are 350 open federal grants in health that small businesses may apply for; 33 close within 30 days. The median award ceiling is $500,000; this grant offers up to $600,000. The agencies offering the most are National Institutes of Health, Centers for Disease Control and Prevention - ERA and Centers for Disease Control - NCBDDD. Grants in this field stay open a median of 1031 days; this one is open for 1137 days.

Who has won this program before

The largest grants and cooperative agreements under assistance listing 93.393 with payments since Oct 1, 2025, from USAspending.gov. Amounts are each award's total.

Other open grants in the same program

Under assistance listing 93.393, the federal program this grant is paid from.

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
National Institutes of Health
Closes Nov 6, 2026 · 17 days left
Grant · Up to $350,000 an award · PAR-25-095
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
National Institutes of Health
Closes Nov 17, 2026 · 28 days left
Grant · Up to $200,000 an award · PAR-25-096
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
National Institutes of Health
Closes Jan 7, 2027
Grant · PAR-25-167
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
National Institutes of Health
Closes Jan 7, 2027
Grant · PAR-25-069
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
National Institutes of Health
Closes Jan 7, 2027
Grant · PAR-25-070

More open grants from the National Institutes of Health

340 open grants from this agency accept small businesses, with $356.4 million in total program funding listed.

Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional)
National Institutes of Health
Closes Oct 20, 2026 · today
Grant · Up to $750,000 an award · RFA-DK-27-120
Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical Trial Required)
National Institutes of Health
Closes Oct 22, 2026 · 2 days left
Grant · RFA-MH-27-140
GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)
National Institutes of Health
Closes Oct 30, 2026 · 10 days left
Cooperative agreement · Up to $1.2 million an award · RFA-HG-27-011
GREGoRi Innovation Projects (U01 Clinical Trial Optional)
National Institutes of Health
Closes Oct 30, 2026 · 10 days left
Cooperative agreement · Up to $500,000 an award · RFA-HG-27-013
GREGoRi Technology Integration Center (U01, Clinical Trials Optional)
National Institutes of Health
Closes Oct 30, 2026 · 10 days left
Cooperative agreement · Up to $2.2 million an award · RFA-HG-27-012

All open federal grants for small businesses